Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018

Publisher Name :
Date: 04-Jun-2018
No. of pages: 133
This report is available at 20% Discount for Single User License till 03 August 2018. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, "Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Electrophysiology Ablation Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Ablation Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Electrophysiology Ablation Catheters under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

This report is available at 20% Discount for Single User License till 03 August 2018. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Electrophysiology Ablation Catheters - Medical Devices Pipeline Assessment, 2018

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Electrophysiology Ablation Catheters Overview 9
3 Products under Development 10
3.1 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
3.2 Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
3.3 Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
3.4 Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
3.5 Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
3.6 Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
4 Electrophysiology Ablation Catheters - Pipeline Products under Development by Companies 16
4.1 Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
4.2 Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18
5 Electrophysiology Ablation Catheters Companies and Product Overview 20
5.1 Ablacon Inc Company Overview 20
5.2 Advanced Cardiac Therapeutics, Inc. Company Overview 21
5.3 Apama Medical, Inc. Company Overview 24
5.4 Biosense Webster Inc Company Overview 25
5.5 BioTex Inc Company Overview 27
5.6 Boston Scientific Corp Company Overview 29
5.7 CardioFocus Inc Company Overview 36
5.8 CardioNova Ltd Company Overview 41
5.9 CathEffects LLC Company Overview 42
5.10 CathRx Ltd Company Overview 43
5.11 Cibiem Inc Company Overview 46
5.12 Columbia University Company Overview 49
5.13 Cordis Corp Company Overview 50
5.14 CryoTherapeutics Gmbh Company Overview 51
5.15 Epicardial Technologies Inc (Inactive) Company Overview 52
5.16 FocusStart LLC Company Overview 53
5.17 Interventional Imaging, Inc. Company Overview 54
5.18 Iowa Approach Inc. Company Overview 55
5.19 Maestro Heart SA Company Overview 58
5.20 Mayo Clinic Company Overview 59
5.21 Medlumics SL Company Overview 60
5.22 MedWaves Inc Company Overview 61
5.23 MicroPort Scientific Corp Company Overview 62
5.24 North Carolina State University Company Overview 64
5.25 Northwestern University Company Overview 65
5.26 Novasentis Inc Company Overview 66
5.27 SCR, Inc. Company Overview 67
5.28 Seattle Children's Hospital Company Overview 68
5.29 Sotera Medical Corp Company Overview 69
5.30 St. Jude Medical LLC Company Overview 70
5.31 Stereotaxis Inc Company Overview 71
5.32 University of Michigan Company Overview 72
5.33 University of Rochester Company Overview 73
5.34 University of Texas Medical Branch at Galveston Company Overview 74
5.35 Vanderbilt University Company Overview 75
5.36 Vimecon GmbH Company Overview 76
5.37 Vivonics, Inc. Company Overview 79
5.38 Voyage Medical (Inactive) Company Overview 80
6 Electrophysiology Ablation Catheters- Recent Developments 81
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 81
6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 83
6.3 May 09, 2018: CardioFocus Announces Successful Live Case Featuring HeartLight X3 System 83
6.4 May 07, 2018: CardioFocus Announces FDA Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Paroxysmal Atrial Fibrillation 84
6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 85
6.6 May 02, 2018: Biosense Webster Launches Study To Evaluate Novel High Power, Short Duration Modality For Treatment Of Atrial Fibrillation 85
6.7 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 86
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 88
6.9 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 89
6.10 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 91
6.11 Mar 19, 2018: Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation 91
6.12 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 92
6.13 Feb 26, 2018: CardioFocus Announces Initiation of HeartLight X3 Clinical Evaluation 94
6.14 Feb 23, 2018: Atrial fibrillation patients benefit most from this treatment 95
6.15 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 96
6.16 Jan 31, 2018: First Triojection Cases in Germany were Recently Completed by Prof. Dr. Thomas Vogl MD 98
6.17 Jan 31, 2018: Allegheny Health Network Neurosurgeons First in Region to Provide New Treatment for Painful Spinal Tumors 98
6.18 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 99
6.19 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 99
6.20 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 100
6.21 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 100
6.22 Nov 28, 2017: MedLumics Appoints Medtech Industry Veterans James Greene as Chief Executive Officer and Giovanni Leo as Member of the Board of Directors 101
6.23 Nov 21, 2017: European doctors learn to access the heart from any approach with Baylis devices and expanded training program 102
6.24 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 103
6.25 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 106
6.26 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 107
6.27 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 108
6.28 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 109
6.29 Oct 25, 2017: Bard Announces Third Quarter Results 111
6.30 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 112
6.31 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 113
6.32 Sep 27, 2017: CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation 114
6.33 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 114
6.34 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 116
6.35 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 117
6.36 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 119
6.37 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 120
6.38 Aug 01, 2017: FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization 121
6.39 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 122
6.40 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 124
6.41 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 124
6.42 Jul 11, 2017: Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation 125
6.43 Jul 07, 2017: MPSC New COO Glendy Wang on Board 126
6.44 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 126
6.45 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 128
7 Appendix 130
7.1 Methodology 130
7.2 About GlobalData 133
7.3 Contact Us 133
7.4 Disclaimer 133

1.1 List of Tables
Table 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
Table 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
Table 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
Table 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
Table 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
Table 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
Table 7: Electrophysiology Ablation Catheters Companies - Pipeline Products by Stage of Development 16
Table 8: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 18
Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 10: Ablasense - Product Status 20
Table 11: Ablasense - Product Description 20
Table 12: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 13: ACT Cardiac Ablation Catheter - Product Status 21
Table 14: ACT Cardiac Ablation Catheter - Product Description 21
Table 15: Advanced Cardiac Therapeutics, Inc. - Ongoing Clinical Trials Overview 22
Table 16: ACT Cardiac Ablation Catheter - A Randomized Controlled Clinical Evaluation of the DiamondTemp System for the Treatment of Paroxysmal Atrial Fibrillation 23
Table 17: ACT Cardiac Ablation Catheter - Advanced Cardiac Therapeutics DiamondTemp Temperature-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 23
Table 18: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 19: Apama RF PVI Balloon Catheter System - Product Status 24
Table 20: Apama RF PVI Balloon Catheter System - Product Description 24
Table 21: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 22: CARTO SMARTTOUCH 5D Catheter - Product Status 25
Table 23: CARTO SMARTTOUCH 5D Catheter - Product Description 25
Table 24: Next Generation Ablation Catheter - Product Status 26
Table 25: Next Generation Ablation Catheter - Product Description 26
Table 26: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 27: Cooled Tip Catheter - Product Status 27
Table 28: Cooled Tip Catheter - Product Description 27
Table 29: Water-cooled Catheter - Product Status 28
Table 30: Water-cooled Catheter - Product Description 28
Table 31: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 32: Cryo Balloon Catheter - Product Status 29
Table 33: Cryo Balloon Catheter - Product Description 29
Table 34: DirectSense Rx Catheter - Product Status 30
Table 35: DirectSense Rx Catheter - Product Description 30
Table 36: Force Sensing Afib Catheter - Product Status 30
Table 37: Force Sensing Afib Catheter - Product Description 30
Table 38: IntellaNav MiFi OI AF Ablation Catheter - Product Status 31
Table 39: IntellaNav MiFi OI AF Ablation Catheter - Product Description 31
Table 40: Next Generation Blazer Catheter - Product Status 31
Table 41: Next Generation Blazer Catheter - Product Description 32
Table 42: Next Generation IntellaTip Catheter - Product Status 32
Table 43: Next Generation IntellaTip Catheter - Product Description 32
Table 44: Boston Scientific Corp - Ongoing Clinical Trials Overview 33
Table 45: Next Generation IntellaTip Catheter - Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 34
Table 46: IntellaNav MiFi OI AF Ablation Catheter - Electrical Coupling Information from the Rhythmia HDx Mapping System and Direct Sense Technology in the Treatment of Paroxysmal Atrial Fibrillation - A Non-randomized, Prospective Study 35
Table 47: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 48: HeartLight Excalibur Balloon - Product Status 36
Table 49: HeartLight Excalibur Balloon - Product Description 36
Table 50: HeartLight X3 System - Product Status 37
Table 51: HeartLight X3 System - Product Description 37
Table 52: CardioFocus Inc - Ongoing Clinical Trials Overview 38
Table 53: HeartLight Excalibur Balloon - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation 39
Table 54: HeartLight X3 System - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation 40
Table 55: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 56: Electrophysiology Catheter - Atrial Fibrillation - Product Status 41
Table 57: Electrophysiology Catheter - Atrial Fibrillation - Product Description 41
Table 58: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 42
Table 59: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status 42
Table 60: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description 42
Table 61: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Table 62: CathRx 4mm Therapeutic Catheter - Product Status 43
Table 63: CathRx 4mm Therapeutic Catheter - Product Description 43
Table 64: CathRx 8mm Therapeutic Catheter - Product Status 44
Table 65: CathRx 8mm Therapeutic Catheter - Product Description 44
Table 66: Khelix Irrigated Ablation EP Catheter - Product Status 44
Table 67: Khelix Irrigated Ablation EP Catheter - Product Description 45
Table 68: Khelix Non-Irrigated Ablation EP Catheter - Product Status 45
Table 69: Khelix Non-Irrigated Ablation EP Catheter - Product Description 45
Table 70: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 71: Catheter-Based Carotid Body Ablation System - Product Status 46
Table 72: Catheter-Based Carotid Body Ablation System - Product Description 46
Table 73: Cibiem Inc - Ongoing Clinical Trials Overview 47
Table 74: Catheter-Based Carotid Body Ablation System - First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study 48
Table 75: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 49
Table 76: Optically-Integrated RFA Catheter - Product Status 49
Table 77: Optically-Integrated RFA Catheter - Product Description 49
Table 78: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 50
Table 79: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status 50
Table 80: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description 50
Table 81: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 51
Table 82: Cryotherapy System - Coronary Artery Disease - Product Status 51
Table 83: Cryotherapy System - Coronary Artery Disease - Product Description 51
Table 84: Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52
Table 85: Epicardial Access Device - Product Status 52
Table 86: Epicardial Access Device - Product Description 52
Table 87: FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 53
Table 88: Anti-coagulum Cardiac Ablation Catheter - Product Status 53
Table 89: Anti-coagulum Cardiac Ablation Catheter - Product Description 53
Table 90: Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
Table 91: Atrial Fibrillation Catheter - Product Status 54
Table 92: Atrial Fibrillation Catheter - Product Description 54
Table 93: Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 94: MaPP-CS - Product Status 55
Table 95: MaPP-CS - Product Description 55
Table 96: ROF-AC - Product Status 56
Table 97: ROF-AC - Product Description 56
Table 98: ROF-AS - Product Status 56
Table 99: ROF-AS - Product Description 57
Table 100: Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 58
Table 101: Maestro-AF Catheter System - Product Status 58
Table 102: Maestro-AF Catheter System - Product Description 58
Table 103: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 59
Table 104: Pulmonary Vein Ablation Device - Product Status 59
Table 105: Pulmonary Vein Ablation Device - Product Description 59
Table 106: Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 60
Table 107: AblaView - Product Status 60
Table 108: AblaView - Product Description 60
Table 109: MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 110: Arrhythmia Catheters - Product Status 61
Table 111: Arrhythmia Catheters - Product Description 61
Table 112: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 62
Table 113: Circular Ablation Catheter - Product Status 62
Table 114: Circular Ablation Catheter - Product Description 62
Table 115: Voyager Irrigated RF Ablation Catheter - Product Status 63
Table 116: Voyager Irrigated RF Ablation Catheter - Product Description 63
Table 117: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 64
Table 118: Robotic Catheter - Product Status 64
Table 119: Robotic Catheter - Product Description 64
Table 120: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 65
Table 121: Cardiac Catheter - Product Status 65
Table 122: Cardiac Catheter - Product Description 65
Table 123: Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 124: Electroactive Polymer Based Steerable Catheter - Product Status 66
Table 125: Electroactive Polymer Based Steerable Catheter - Product Description 66
Table 126: SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 127: Atrial Fibrillation Device - Product Status 67
Table 128: Atrial Fibrillation Device - Product Description 67
Table 129: Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 68
Table 130: Ablation Catheter - Heart Arrhythmia - Product Status 68
Table 131: Ablation Catheter - Heart Arrhythmia - Product Description 68
Table 132: Sotera Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 69
Table 133: Sotera - Atrial Fibrillation Device - Product Status 69
Table 134: Sotera - Atrial Fibrillation Device - Product Description 69
Table 135: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 70
Table 136: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Status 70
Table 137: TactiCath Contact Force Ablation Catheter - Sensor Enabled - Product Description 70
Table 138: Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 139: Next Generation Irrigated Magnetic Catheter - Product Status 71
Table 140: Next Generation Irrigated Magnetic Catheter - Product Description 71
Table 141: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 72
Table 142: Non-Contact Mapping Catheter - Product Status 72
Table 143: Non-Contact Mapping Catheter - Product Description 72
Table 144: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 73
Table 145: RF Ablation Catheter - Product Status 73
Table 146: RF Ablation Catheter - Product Description 73
Table 147: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 74
Table 148: Ablation Catheter - Product Status 74
Table 149: Ablation Catheter - Product Description 74
Table 150: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 75
Table 151: Temperature Controlled Catheter - Product Status 75
Table 152: Temperature Controlled Catheter - Product Description 75
Table 153: Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
Table 154: Vimecon Laser CAI Catheter - Product Status 76
Table 155: Vimecon Laser CAI Catheter - Product Description 76
Table 156: Vimecon GmbH - Ongoing Clinical Trials Overview 77
Table 157: Vimecon Laser CAI Catheter - A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF) 78
Table 158: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
Table 159: Catheter Guidance System - Product Status 79
Table 160: Catheter Guidance System - Product Description 79
Table 161: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80
Table 162: IRIS Ablation System - Product Status 80
Table 163: IRIS Ablation System - Product Description 80
Table 164: Glossary 132

1.2 List of Figures
Figure 1: Electrophysiology Ablation Catheters - Pipeline Products by Stage of Development 10
Figure 2: Electrophysiology Ablation Catheters - Pipeline Products by Segment 11
Figure 3: Electrophysiology Ablation Catheters - Pipeline Products by Territory 12
Figure 4: Electrophysiology Ablation Catheters - Pipeline Products by Regulatory Path 13
Figure 5: Electrophysiology Ablation Catheters - Pipeline Products by Estimated Approval Date 14
Figure 6: Electrophysiology Ablation Catheters - Ongoing Clinical Trials 15
  • Global Stone Extraction Catheter Market Professional Survey Report 2018
    Published: 19-Jul-2018        Price: US 3500 Onwards        Pages: 108
    This report studies the global Stone Extraction Catheter market status and forecast, categorizes the global Stone Extraction Catheter market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Stone Extraction Catheter market is valued at million US$ in 2017 and will reach mil......
  • 2018-2023 Global Intermittent Catheters Consumption Market Report
    Published: 17-Jul-2018        Price: US 4660 Onwards        Pages: 130
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Intermittent Catheters market for 2018-2023. Urinary catheters are hollow, partially flexible tubes that collect urine from the bladder. Urinary catheters come in many sizes and types. There are three main types of catheters including: Indwelling Catheters (Urethral or Suprapubic Catheters), External Catheters (Condom Catheters) and Short-Term (Inter......
  • 2018 Top 5 Intermittent Catheters Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 17-Jul-2018        Price: US 4960 Onwards        Pages: 128
    Urinary catheters are hollow, partially flexible tubes that collect urine from the bladder. Urinary catheters come in many sizes and types. There are three main types of catheters including: Indwelling Catheters (Urethral or Suprapubic Catheters), External Catheters (Condom Catheters) and Short-Term (Intermittent) Catheters. Intermittent catheters are intended to be used to provide an intermittent pathway for short term drainage of fluids from the bladder for either male (N......
  • Global Peripheral Intravenous Catheter Market 2018-2023
    Published: 13-Jul-2018        Price: US 3000 Onwards        Pages: 128
    Chinese peripheral intravenous catheter market is anticipated to grow at a CAGR of 7.5% by 2023, according to a new report published by Gen Consulting Company. The report segments the market and forecasts its size, by volume and value, on the basis of application (hospitals & clinics, homecare, etc.), and by geography (North China, Northeast China, East China, South Central China, Southwest China, Northwest China). The report covers forecast and analysis for the Peripheral Intraveno......
  • Global and United States PTCA Catheters Market Research by Company, Type & Application 2013-2025
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 163
    Summary Market Segment as follows: By Type Below 10mm 10mm - 15mm 15mm - 20mm 20mm - 30mm Above 30mm By Application Angina Myocardial Infarction Others By Company Aachen Resonance (Germany) Acrostak (Switzerland) Aesculap (Germany) Alvimedica (Turkey) AngioScore (USA) Arthesys (France) Asahi Intecc (Japan) Balton (......
  • Global Central Venous Catheters Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 05-Jul-2018        Price: US 3480 Onwards        Pages: 135
    A central venous catheter, also called a central line, is a long, thin, flexible tube used to give medicines, fluids, nutrients, or blood products over a long period of time, usually several weeks or more. A catheter is often inserted in the arm or chest through the skin into a large vein. Scope of the Report: This report focuses on the Central Venous Catheters in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. T......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Central Venous Catheters Market 2018, Forecast to 2023
    Published: 05-Jul-2018        Price: US 4880 Onwards        Pages: 130
    A central venous catheter, also called a central line, is a long, thin, flexible tube used to give medicines, fluids, nutrients, or blood products over a long period of time, usually several weeks or more. A catheter is often inserted in the arm or chest through the skin into a large vein. Scope of the Report: This report focuses on the Central Venous Catheters in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. T......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Medical Catheters Market 2018, Forecast to 2023
    Published: 03-Jul-2018        Price: US 4880 Onwards        Pages: 146
    Medical Catheters are tubes that can be inserted into a body cavity, vessel or duct, usually to allow for the administration of fluids, medications or gases or to drain fluids or urine from the body. Examples of some types of catheter include intravenous catheters, urinary catheters, etc. Scope of the Report: This report focuses on the Medical Catheters in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Thi......
  • Global Medical Catheters Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 03-Jul-2018        Price: US 3480 Onwards        Pages: 145
    Medical Catheters are tubes that can be inserted into a body cavity, vessel or duct, usually to allow for the administration of fluids, medications or gases or to drain fluids or urine from the body. Examples of some types of catheter include intravenous catheters, urinary catheters, etc. Scope of the Report: This report focuses on the Medical Catheters in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Thi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs